Insider Purchases: Inside the Buy
Tag: investing
Proto Labs (PRLB): The CEO Bought Shares. Should You?
The CEO of Proto Labs just invested in his own company — but it’s not just him. Wall Street giants are in, revenue’s at record levels, and PRLB might be building toward a breakout. Should you 3D-print it into your portfolio?
MSCI Keeps Winning — and the CEO Keeps Buying In
MSCI delivers world-class data tools for investors—and its CEO just bought in big. With soaring revenue, recurring subscriptions, and loyal institutions, is this still a buy? Or has the stock outpaced its fundamentals?
Insiders Bought "MicroStrategy" Shares at $90. You’re Paying $394.66. Should You?
MSTR insiders are buying, but not the stock you think. They bought STRC at $90 — while MSTR trades near $400. What gives? We break down the numbers, the Bitcoin twist, and what might be worth nibbling on.
New CEO Buys In at Dave & Buster’s ($PLAY). Who Doesn’t Like a Little PLAY in Their Portfolio — or Life?
New CEO Tarun Lal takes the reins—and a big slice of $PLAY stock. With insiders buying, institutions overloaded, and sales trends improving, could this be the next comeback classic of the “entertainment” era?
Healthpeak Properties (DOC): Insiders Are Buying—Should You?
📈 Healthpeak Properties (DOC) insiders are buying—and not just a little. But with a forward P/E north of 70 and a few post-merger integration challenges, is this stock still a hidden gem or more of a polished maybe? Dive in for the full take.
Penn Entertainment: A Double-Down That’s Finally Paying Off?
Penn Entertainment ($PENN) is showing signs of life — insiders are doubling down, revenues are climbing, and digital bets are growing fast. With shares rebounding, is it time to follow the high-rollers or step back from the table? 🎰📈
Insider Intel: What CEOs Are Buying (And What They Hope You Won’t Notice)
CEOs and top execs are putting their money where their mouth is—but should you follow their lead? From Moderna's biotech bet to Permian's big energy play, this week's insider moves reveal patterns worth watching. Dive into the details and spot the next market trend before it hits the headlines.
Big Bets or Big Blunders: Notable Insider Moves In the First Half of February 2025 - ASH, IMNM, EL, MRK, SIRI, KMT, MAGN, OXY, UFI, MTH, TKO, HI, ENTA, NVCT, OCX, SYNA, NINE, HP, BZH, MNR, BDX, LFUS, MUR, AESI
Big Bets or Red Flags? What Insider Buying Tells Us
CEOs, directors, and 10% owners are making big moves—and they aren’t subtle about it. From Ashland’s bullish buys to Buffett’s continued love affair with SiriusXM and Occidental, insider trades are signaling some serious market confidence. Are these just corporate optics or a true sign of undervalued opportunities? Let’s break down the biggest insider moves—and what they mean for your portfolio.
Big Bets or Big Blunders: Notable Insider Moves Toward the End of January 2025 - ALLY, TKO, ADBE, GM, SFD, BATRA, XRAY, TREX
Insider Buys Are Heating Up—Should You Pay Attention?
CEOs and key executives are making big bets on stocks like Ally Financial, Adobe, and TKO Group. With millions of insider dollars pouring in, are these signals of strength or just corporate window dressing? From undervalued gems to conviction buys, here’s what the market pros are seeing—and why it matters for your portfolio.